세계의 첨단 상처 치료 시장 2024-2030 : 제품별 (습윤, 항균), 용도별 (만성 상처, 급성 상처), 최종 용도별 (병원, 전문 클리닉, 재택 의료), 지역별

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Application
1.1.3. End-use
1.1.4. Regional
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Application outlook
2.2.3. End-use outlook
2.2.4. Mode of purchase outlook
2.2.5. Distribution channel outlook
2.3. Competitive Insights
Chapter 3. Wound Care Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing prevalence of chronic diseases and conditions affecting wound healing capabilities
3.2.1.2. Introduction of innovative and advanced wound products
3.2.1.3. Rising geriatric population
3.2.1.4. Increasing number of road accidents, trauma cases, and burns
3.2.1.5. Increasing number of surgeries
3.2.2. Market Restraint Analysis
3.2.2.1. Delayed Diagnosis and lower treatment rates in emerging nations
3.2.3. Market Opportunity Analysis
3.3. U.S. Wound Care Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic Landscape
3.3.3. Covid-19 Impact Analysis
Chapter 4. Wound Care Market: Product Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Moist wound care
4.1.2. Antimicrobial wound care
4.1.3. Active wound care
4.2. Product Market Share, 2018 & 2030
4.3. Segment Dashboard
4.4. U.S. Wound Care Market by Product Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2023 to 2030 for the following
4.5.1. Moist wound care
4.5.1.1. Moist wound care market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.2. Foam dressings
4.5.1.2.1. Foam dressings market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.3. Hydrocolloid dressings
4.5.1.3.1. Hydrocolloid dressings market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.4. Film dressings
4.5.1.4.1. Film Dressings Market Estimates and forecast 2018 to 2030 (USD Million)
4.5.1.5. Alginate dressings
4.5.1.5.1. Alginate dressings market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.6. Hydrogel dressings
4.5.1.6.1. Hydrogel Dressings Market Estimates and forecast 2018 to 2030 (USD Million)
4.5.1.7. Collagen dressings
4.5.1.7.1. Collagen dressings market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.8. Other advanced dressings
4.5.1.8.1. Other advanced dressings market estimates and forecast 2018 to 2030 (USD Million)
4.5.2. Antimicrobial wound care
4.5.2.1. Antimicrobial wound care market estimates and forecast 2018 to 2030 (USD Million)
4.5.2.2. Silver
4.5.2.2.1. Silver market estimates and forecast 2018 to 2030 (USD Million)
4.5.2.3. Non-silver
4.5.2.3.1. Non-silver market estimates and forecast 2018 to 2030 (USD Million)
4.5.3. Active wound care
4.5.3.1. Active wound care market estimates and forecast 2018 to 2030 (USD Million)
4.5.3.2. Biomaterials
4.5.3.2.1. Biomaterials market estimates and forecast 2018 to 2030 (USD Million)
4.5.3.3. Skin-substitute
4.5.3.3.1. Skin-substitute market estimates and forecast 2018 to 2030 (USD Million)
4.5.3.4. Growth factors
4.5.3.4.1. Growth factors market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Wound Care Market: Application Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Acute Wounds
5.1.2. Chronic Wounds
5.2. Application Market Share, 2018 & 2030
5.3. Segment Dashboard
5.4. U.S. Wound Care Market by Application Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2023 to 2030 for the following
5.5.1. Acute Wounds
5.5.1.1. Acute wounds market estimates and forecast 2018 to 2030 (USD Million)
5.5.1.2. Surgical & traumatic wounds
5.5.1.2.1. Surgical & traumatic wounds market estimates and forecast 2018 to 2030 (USD Million)
5.5.1.3. Burns
5.5.1.3.1. Burns market estimates and forecast 2018 to 2030 (USD Million)
5.5.2. Chronic Wounds
5.5.2.1. Chronic wounds market estimates and forecast 2018 to 2030 (USD Million)
5.5.2.2. Diabetic foot ulcers
5.5.2.2.1. Diabetic foot ulcers market estimates and forecast 2018 to 2030 (USD Million)
5.5.2.3. Pressure ulcers
5.5.2.3.1. Pressure ulcers market estimates and forecast 2018 to 2030 (USD Million)
5.5.2.4. Venous leg ulcers
5.5.2.4.1. Venous leg ulcers market estimates and forecast 2018 to 2030 (USD Million)
5.5.2.5. Others chronic wounds
5.5.2.5.1. Others chronic wounds market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Wound Care Devices: End-Use Estimates & Trend Analysis
6.1. Definitions and Scope
6.1.1. Hospitals
6.1.2. Specialty clinics
6.1.3. Home healthcare
6.1.4. Others
6.2. End-use Market Share, 2018 & 2030
6.3. Segment Dashboard
6.4. U.S. Wound Care Market by End-use Outlook
6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5.1. Hospitals
6.5.1.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
6.5.2. Specialty clinics
6.5.2.1. Specialty clinics centers market estimates and forecast 2018 to 2030 (USD Million)
6.5.3. Home healthcare
6.5.3.1. Home healthcare market estimates and forecast 2018 to 2030 (USD Million)
6.5.4. Others
6.5.4.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 7. Wound Care Market: Regional Estimates & Trend Analysis
7.1. Regional market share analysis, 2023 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Regional Market Share and Leading Players, 2023
7.4.1. North America
7.4.2. Europe
7.4.3. Asia Pacific
7.4.4. Latin America
7.4.5. Middle East and Africa
7.5. Market Application, & Forecasts and Trend Analysis, 2018 to 2030
7.6. North America
7.6.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.6.2. U.S.
7.6.2.1. Key country dynamics
7.6.2.2. Competitive scenario
7.6.2.3. Regulatory framework
7.6.2.4. Reimbursement scenario
7.6.2.5. U.S. market estimates and forecasts, 2018 – 2030
7.6.3. Canada
7.6.3.1. Key country dynamics
7.6.3.2. Competitive scenario
7.6.3.3. Regulatory framework
7.6.3.4. Reimbursement scenario
7.6.3.5. Canada market estimates and forecasts, 2018 – 2030
7.7. Europe
7.7.1. UK
7.7.1.1. Key country dynamics
7.7.1.2. Competitive scenario
7.7.1.3. Regulatory framework
7.7.1.4. Reimbursement scenario
7.7.1.5. UK market estimates and forecasts, 2018 – 2030
7.7.2. Germany
7.7.2.1. Key country dynamics
7.7.2.2. Competitive scenario
7.7.2.3. Regulatory framework
7.7.2.4. Reimbursement scenario
7.7.2.5. Germany market estimates and forecasts, 2018 – 2030
7.7.3. France
7.7.3.1. Key country dynamics
7.7.3.2. Competitive scenario
7.7.3.3. Regulatory framework
7.7.3.4. Reimbursement scenario
7.7.3.5. France market estimates and forecasts, 2018 – 2030
7.7.4. Italy
7.7.4.1. Key country dynamics
7.7.4.2. Competitive scenario
7.7.4.3. Regulatory framework
7.7.4.4. Reimbursement scenario
7.7.4.5. Italy market estimates and forecasts, 2018 – 2030
7.7.5. Spain
v7.7.5.1. Key country dynamics
7.7.5.2. Competitive scenario
7.7.5.3. Regulatory framework
7.7.5.4. Reimbursement scenario
7.7.5.5. Spain market estimates and forecasts, 2018 – 2030
7.7.6. Denmark
7.7.6.1. Key country dynamics
7.7.6.2. Competitive scenario
7.7.6.3. Regulatory framework
7.7.6.4. Reimbursement scenario
7.7.6.5. Denmark market estimates and forecasts, 2018 – 2030
7.7.7. Sweden
7.7.7.1. Key country dynamics
7.7.7.2. Competitive scenario
7.7.7.3. Regulatory framework
7.7.7.4. Reimbursement scenario
7.7.7.5. Sweden market estimates and forecasts, 2018 – 2030
7.7.8. Norway
7.7.8.1. Key country dynamics
7.7.8.2. Competitive scenario
7.7.8.3. Regulatory framework
7.7.8.4. Reimbursement scenario
7.7.8.5. Norway market estimates and forecasts, 2018 – 2030
7.8. Asia Pacific
7.8.1. Japan
7.8.1.1. Key country dynamics
7.8.1.2. Competitive scenario
7.8.1.3. Regulatory framework
7.8.1.4. Reimbursement scenario
7.8.1.5. Japan market estimates and forecasts, 2018 – 2030
7.8.2. India
7.8.2.1. Key country dynamics
7.8.2.2. Competitive scenario
7.8.2.3. Regulatory framework
7.8.2.4. Reimbursement scenario
7.8.2.5. India market estimates and forecasts, 2018 – 2030
7.8.3. China
7.8.3.1. Key country dynamics
7.8.3.2. Competitive scenario
7.8.3.3. Regulatory framework
7.8.3.4. Reimbursement scenario
7.8.3.5. China market estimates and forecasts, 2018 – 2030
7.8.4. South Korea
7.8.4.1. Key country dynamics
7.8.4.2. Competitive scenario
7.8.4.3. Regulatory framework
7.8.4.4. Reimbursement scenario
7.8.4.5. South Korea market estimates and forecasts, 2018 – 2030
7.8.5. Australia
7.8.5.1. Key country dynamics
7.8.5.2. Competitive scenario
7.8.5.3. Regulatory framework
7.8.5.4. Reimbursement scenario
7.8.5.5. Australia market estimates and forecasts, 2018 – 2030
7.8.6. Thailand
7.8.6.1. Key country dynamics
7.8.6.2. Competitive scenario
7.8.6.3. Regulatory framework
7.8.6.4. Reimbursement scenario
7.8.6.5. Thailand market estimates and forecasts, 2018 – 2030
7.9. Latin America
7.9.1. Brazil
7.9.1.1. Key country dynamics
7.9.1.2. Competitive scenario
7.9.1.3. Regulatory framework
7.9.1.4. Reimbursement scenario
7.9.1.5. Brazil market estimates and forecasts, 2018 – 2030
7.9.2. Mexico
7.9.2.1. Key country dynamics
7.9.2.2. Competitive scenario
7.9.2.3. Regulatory framework
7.9.2.4. Reimbursement scenario
7.9.2.5. Mexico market estimates and forecasts, 2018 – 2030
7.9.3. Argentina
7.9.3.1. Key country dynamics
7.9.3.2. Competitive scenario
7.9.3.3. Regulatory framework
7.9.3.4. Reimbursement scenario
7.9.3.5. Argentina market estimates and forecasts, 2018 – 2030
7.10. MEA
7.10.1. South Africa
7.10.1.1. Key country dynamics
7.10.1.2. Competitive scenario
7.10.1.3. Regulatory framework
7.10.1.4. Reimbursement scenario
7.10.1.5. South Africa market estimates and forecasts, 2018 – 2030
7.10.2. Saudi Arabia
7.10.2.1. Key country dynamics
7.10.2.2. Competitive scenario
7.10.2.3. Regulatory framework
7.10.2.4. Reimbursement scenario
7.10.2.5. Saudi Arabia market estimates and forecasts, 2018 – 2030
7.10.3. UAE
7.10.3.1. Key country dynamics
7.10.3.2. Competitive scenario
7.10.3.3. Regulatory framework
7.10.3.4. Reimbursement scenario
7.10.3.5. UAE market estimates and forecasts, 2018 – 2030
7.10.4. Kuwait
7.10.4.1. Key country dynamics
7.10.4.2. Competitive scenario
7.10.4.3. Regulatory framework
7.10.4.4. Reimbursement scenario
7.10.4.5. Kuwait market estimates and forecasts, 2018 – 2030
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Innovators
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2023
8.3.4. Smith & Nephew PLC
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Mölnlycke Health Care AB
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. ConvaTec Group PLC
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. Baxter International
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. URGO Medical
8.3.8.1. Financial performance
8.3.8.2. Product benchmarking
8.3.8.3. Strategic initiatives
8.3.9. Coloplast Corp.
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Medtronic
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives
8.3.11. 3M
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Product benchmarking
8.3.11.4. Strategic initiatives
8.3.12. Derma Sciences (Integra LifeSciences)
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Product benchmarking
8.3.12.4. Strategic initiatives
8.3.13. Medline Industries, Inc.
8.3.13.1. Company overview
8.3.13.2. Financial performance
8.3.13.3. Product benchmarking
8.3.13.4. Strategic initiatives